Worthington Enterprises, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 17, 2025, discloses the unaudited financial results for Worthington Enterprises, Inc. for the second quarter of fiscal 2026 ended November 30, 2025. The filing accompanies a conference call transcript (Exhibit 99.1) discussing operational performance, market outlook, and non-GAAP financial measures.
Key Financial Metrics
Quarterly Results (Q2 Fiscal 2026 vs. Q2 Fiscal 2025):
- Net Earnings (GAAP): $27.0 million (Q2 2026) compared to $28.0 million (Q2 2025).
- Net Earnings Attributable to Controlling Interest: $27.3 million (Q2 2026) compared to $28.3 million (Q2 2025).
- Adjusted EBITDA (Non-GAAP): $60.5 million (Q2 2026) compared to $56.2 million (Q2 2025).
- Free Cash Flow (Non-GAAP): $39.1 million (Q2 2026) compared to $39.1 million (Q2 2025).
Trailing Twelve Months (TTM) Ended November 30, 2025:
- TTM Adjusted EBITDA: $284.4 million.
- TTM Net Earnings Margin (GAAP): 8.4%.
- TTM Adjusted EBITDA Margin (Non-GAAP): 22.7%.
- TTM Free Cash Flow: $160.7 million.
- Net Debt: $125.0 million (Long-term debt of $305.3 million less cash of $180.3 million).
- Net Debt to TTM Adjusted EBITDA: 0.44x.
Material Changes and Organic Performance
Consolidated net sales increased 19.5% to $327.5 million in Q2 2026 from $274.0 million in the prior year period. This growth was partially driven by the acquisition of Elgen on June 18, 2025, which contributed $24.6 million in sales.
Organic Growth (Adjusted Net Sales): Excluding Elgen, adjusted net sales grew 10.5% to $302.9 million.
Expense Management: Consolidated SG&A increased 4.1% to $70.7 million. On an adjusted basis (excluding Elgen), SG&A decreased 1.9% to $66.6 million, indicating improved operational efficiency in core businesses.
Unusual Items Impacting Q2 2026:
- Loss on partial sale of investment in SES: $2.95 million.
- Unrealized loss on investment in marketable securities: $1.24 million.
- Restructuring and other expenses: $1.64 million.
Guidance, Outlook, and Risks
The filing references a conference call where management addressed the outlook for the Registrant and its subsidiaries. The text provided does not contain specific forward-looking numerical guidance for future quarters or fiscal years. Management utilizes non-GAAP measures such as Adjusted EBITDA and Free Cash Flow to evaluate ongoing operational performance, excluding items deemed not indicative of core operations.
Contingencies and Risks: The filing notes that the information furnished is not "filed" under the Exchange Act unless specifically stated, limiting liability under Section 18. The company continues to manage restructuring costs and investment valuation fluctuations.
Investor Verification Checklist
- Verify the full reconciliation of GAAP net earnings to Adjusted EBITDA in Exhibit 99.1 to understand the specific adjustments made for the $2.95 million SES investment loss and $1.24 million unrealized securities loss.
- Confirm the specific contribution of the Elgen acquisition to future revenue streams and integration costs beyond the current quarter.
- Review the detailed breakdown of "Restructuring and other expense" to assess the duration and magnitude of ongoing operational changes.
- Examine the "Financial News Release" referenced in the filing for any updated guidance or market commentary not included in this 8-K text.
- Monitor the Net Debt to Adjusted EBITDA ratio (currently 0.44x) to ensure leverage remains within management's target range as capital expenditures continue.